Cognitive | Page 40 of 47 | SpiritIndia.com

Psychiatry :: UCLA Faculty Recognized for Outstanding Achievement in Psychiatric Research

Three UCLA scientists will be awarded top prizes for psychiatric research on Friday by NARSAD: The Mental Health Research Association, the world’s largest donor-supported organization dedicated to funding innovative research on severe mental illnesses. Lori Altshuler, M.D.; Joaquin M. Fuster, M.D., Ph.D., and Tyrone D. Cannon, Ph.D., all of UCLA’s Semel Institute, will be presented their awards at NARSAD’s 19th annual ceremony in New York City.

Alzheimer’s Disease :: New imaging technique to track progression of alzheimer’s disease

Using an innovative three-dimensional imaging technique, a team of UCLA researchers have tracked how Alzheimer’s disease spreads through the hippocampus ? the area of the brain linked with memory ? in a pattern consistent with the known trajectory of neurofibrilliary tangle dissemination, an accumulation of diseased proteins in the brain cells.

Alzheimer’s Disease :: Common cold leading to Alzheimer’s disease

Viruses linked to the common cold could be causing memory loss and Alzheimer’s disease in millions of people, new research suggests. Experts suspect that common viruses which infect around one billion people worldwide each year may be invading the central nervous system and damaging the brain. In later life this could lead to symptoms of memory loss and declining mental ability.

Neurology :: Vegetables may help protect memory and thinking speed

Vegetables – particularly green, leafy ones – will preserve the brain power if you eat three servings a day, new research shows. People who consumed two or more vegetables a day had a 35 to 40 percent decrease in the decline in thinking ability over six years. That’s the equivalent of being five years younger in age. The study results are published in the Oct. 24 issue of the journal Neurology.

Celiac Disease :: Celiac disease linked to impaired thinking

Impaired thinking may follow the onset or worsening of celiac disease, a common digestive disorder triggered by eating wheat products and other foods containing the protein gluten, as reported in the Archives of Neurology by Dr. Keith A. Josephs and colleagues from the Mayo Clinic College of Medicine, who studied 13 patients who experienced cognitive decline within 2 years of the onset or worsening of celiac disease.

Migraine :: Clinical trial in acute migraine for lead compound tezampanel

TorreyPines Therapeutics, Inc. (Nasdaq: TPTX) today announced the initiation of a Phase IIb clinical trial for its lead product candidate, tezampanel, a novel pain compound in development for the treatment of acute migraine. An AMPA/kainate (AK) receptor antagonist, tezampanel offers a non-narcotic, non-vascular approach to the management of headache pain and represents a potentially promising alternative to current migraine treatments.

Alzheimer’s Disease :: Aricept – donepezil hydrochloride – for dementia in Alzheimer’s Disease

The Food and Drug Administration (FDA) approved Aricept (donepezil hydrochloride) for the treatment of severe dementia in patients with Alzheimer’s Disease.

ADHD :: Preschoolers with ADHD Improve with Low Doses of Medication

The first long-term, large-scale study designed to determine the safety and effectiveness of treating preschoolers who have attention deficit/hyperactivity disorder (ADHD) with methylphenidate (Ritalin) has found that overall, low doses of this medication are effective and safe. However, the study found that children this age are more sensitive than older children to the medication?s side effects and therefore should be closely monitored. The 70-week, six-site study was funded by the National Institutes of Health?s National Institute of Mental Health (NIMH) and was described in several articles in the November 2006 issue of the Journal of the American Academy of Child and Adolescent Psychiatry.

Alzheimer’s Disease :: Antipsychotic Medications Used to Treat Alzheimer’s Patients Found Lacking

Commonly prescribed antipsychotic medications used to treat Alzheimer?s patients with delusions, aggression, hallucinations, and other similar symptoms can benefit some patients, but they appear to be no more effective than a placebo when adverse side effects are considered, according to the first phase of a large-scale clinical trial funded by the National Institutes of Health?s National Institute of Mental Health (NIMH). The trial, known as the Clinical Antipsychotic Trial of Intervention Effectiveness study for Alzheimer?s disease (CATIE-AD), was published in the October 12, 2006, issue of the New England Journal of Medicine.

Anger :: Intermittent Explosive Disorder (IED)

IED is defined as repeated and uncontrollable anger attacks that often become violent. IED is different from common type of anger most people exhibit from time to time when they pout, throw a book down or walk out of the room banging door, activities that are better described as mild temper tantrums.